ARM_logo full.jpg
German Parliament Approves Legislation to Accelerate Access to Life-Changing Cell and Gene Therapies
June 15, 2021 01:00 ET | The Alliance for Regenerative Medicine
GERMAN PARLIAMENT APPROVES LEGISLATION TO ACCELERATE ACCESS TO LIFE-CHANGING CELL AND GENE THERAPIES The Alliance for Regenerative Medicine advocated for reducing the “NUB gap” for advanced...
ARM_logo full.jpg
ARM, EFPIA and EuropaBio Call for Advanced Therapies to be Exempt from EU GMO Legislation
May 25, 2021 08:54 ET | The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO...
ARM_logo full.jpg
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments
March 24, 2021 11:28 ET | The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments European Patients Stand To Benefit From Early Focus On Life-Changing ATMPs BRUSSELS, BELGIUM...
ARM_logo full.jpg
Alliance for Regenerative Medicine Annual Report Highlights Record Sector Growth and Resilience in 2020
March 16, 2021 10:08 ET | The Alliance for Regenerative Medicine
ALLIANCE FOR REGENERATIVE MEDICINE ANNUAL REPORT HIGHLIGHTS RECORD SECTOR GROWTH AND RESILIENCE IN 2020 Sector financing reached $19.9B in 2020, doubling from the previous year; 2021 is...
ARM_logo full.jpg
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan
February 03, 2021 09:00 ET | The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan ATMPs are uniquely positioned to attack cancer at its source, bringing life-changing benefits to patients BRUSSELS, BELGIUM –...
ARM_logo full.jpg
The Alliance for Regenerative Medicine Announces Record Sector Financing in 2020
November 19, 2020 09:36 ET | The Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine Announces Record Sector Financing in 2020 Washington, DC – November 19, 2020 The regenerative medicine sector attracted $15.9 billion in financing through just...
ARM_logo full.jpg
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies
July 29, 2020 02:00 ET | The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies BRUSSELS, BELGIUM. – July...
ARM_logo full.jpg
Alliance for Regenerative Medicine Responds to EU Pharmaceutical Roadmap
July 07, 2020 02:00 ET | The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Responds to EU Pharmaceutical Roadmap Leading international advocacy group calls for effective regulation, clinical trial support, and value-based reimbursement...
ARM_logo full.jpg
The Alliance for Regenerative Medicine Outlines Recommendations on Enabling Cross-border and Regional Access to Advanced Therapy Medicinal Products (ATMPs) in Europe
January 27, 2020 02:00 ET | The Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine Outlines Recommendations on Enabling Cross-border and Regional Access to Advanced Therapy Medicinal Products (ATMPs) in Europe Establish an ATMP coordination...
ARM_logo full.jpg
The Alliance for Regenerative Medicine to host European ATMP Access Meeting in Brussels
December 06, 2019 03:00 ET | The Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine to host European ATMP Access Meeting in Brussels Meeting on 12th December brings together stakeholders from across Europe WASHINGTON, D.C. and BRUSSELS,...